Christine Girges

UCL Queen Square Institute Of Neurology
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Identifying and predicting fast versus slow Parkinson's disease motor progressors using clinical and digital data.

Identifying and predicting fast versus slow Parkinson's disease motor progressors using clinical and digital data.

Journal: BMJ neurology open

Published: May 22, 2026

Genetically proxied GLP1R expression does not predict exenatide response in the Exenatide-PD3 trial.

Genetically proxied GLP1R expression does not predict exenatide response in the Exenatide-PD3 trial.

Journal: Brain : a journal of neurology

Published: April 14, 2026

Observations on an Open-Label Phase 1/2 Dopamine Gene Therapy Trial (OXB-102/Axo-Lenti-PD) in People with Parkinson's Disease.

Observations on an Open-Label Phase 1/2 Dopamine Gene Therapy Trial (OXB-102/Axo-Lenti-PD) in People with Parkinson's Disease.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 20, 2026

Levodopa Efficacy and GLP-1 Receptor Agonists.

Levodopa Efficacy and GLP-1 Receptor Agonists.

Journal: Movement disorders clinical practice

Published: December 10, 2025

Mild-to-moderate depressive symptoms impact on self-reported outcome measures in clinical trials for neurodegenerative diseases.

Mild-to-moderate depressive symptoms impact on self-reported outcome measures in clinical trials for neurodegenerative diseases.

Journal: Clinical trials (London, England)

Published: December 01, 2025

Peripheral and CSF protein quantification in Parkinson's disease and multiple system atrophy-the nucleic acid-linked immuno-sandwich assay.

Peripheral and CSF protein quantification in Parkinson's disease and multiple system atrophy-the nucleic acid-linked immuno-sandwich assay.

Journal: Brain communications

Published: October 08, 2025

Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies.

Quantitative measurements of α-synuclein seeds in CSF inform diagnosis of synucleinopathies.

Journal: Journal of Parkinson's disease

Published: October 03, 2025

Clinical prognostic indicators in multiple system atrophy.

Clinical prognostic indicators in multiple system atrophy.

Journal: Brain : a journal of neurology

Published: September 09, 2025

Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's disease.

Depressive symptoms can negatively influence patient reported disease severity after subthalamic nucleus stimulation for Parkinson's disease.

Journal: Journal of Parkinson's disease

Published: June 26, 2025

Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy.

Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy.

Journal: Annals of neurology

Published: March 25, 2025

Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study.

Diagnostic and prognostic value of α-synuclein seed amplification assay kinetic measures in Parkinson's disease: a longitudinal cohort study.

Journal: The Lancet. Neurology

Published: December 10, 2024

Intronic FGF14 GAA repeat expansions impact progression and survival in multiple system atrophy.

Intronic FGF14 GAA repeat expansions impact progression and survival in multiple system atrophy.

Journal: Brain : a journal of neurology

Published: November 20, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026